Bausch & Lomb launch Obagi’s blockbuster products like Thermage, Fraxel, Vaser & Clear + Brilliant and few more offerings in the pipeline. This strategic move of expanding in the premium skincare segment, would further strengthen Bausch & Lomb’s position in the INR 285 - 290 billion beauty care market, growing at a rate 15 to 20 per cent per annum (As per FICCI Wellness Report 2013).
Kraft Heinz Company's Indian affiliate Kraft Heinz India which is a food and beverage major With partnership with Stop Hunger Now, a non-profit organisation, and Society for Action in Community has launched a mobile medical unit (MMU) service in Kalajore village in Bihar, the company release stated.
The Indian Patent Office has rejected American drug maker Pfizer's patents for its rheumatoid arthritis drug tofacitinib in India.
“After having considered the submissions submitted by the applicant (Pfizer) in the hearing, the written submission and amended claims filed as well as in view of the discussions and findings by me, it is hereby ordered that the invention disclosed and claimed in the instant application is not considered as an invention under the provisions of the Act”, said Bharat N S, assistant controller of patents & designs, Mumbai.
(Business Wire India); RWL Healthworld Ltd. (formerly known as Religare Wellness) has been re-branded as Fortis Health World; and is successfully running a leading e-commerce portal that sells beauty, wellness and health-care products such as baby care products, face and skin care range, home and living utilities as well as diabetic remedies.
Mumbai based pharma major Lupin Limited announced that its subsidiary Lupin Pharmaceuticals Inc (Lupin) has launched its Duloxetine 40 mg delayed-release (DR) capsule, which is the first and only generic Duloxetine formulation to become available in 40 mg dosage strength.
Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval from the United States Food & Drug Administration (FDA) for voriconazole tablets, 50 mg and 200 mg of PF Prism C.V. (Prism).
Teva Pharmaceutical Industries Ltd launch Zecuity, the first and only patch system in US designed to provide relief from migraine. Zecuity is a single-use, disposable patch system that delivers sumatriptan through the skin. Zecuity is a prescription medicine used for the acute treatment of migraine headaches with or without aura in adults.
Sandoz, a Novartis company and a global leader in generic pharmaceuticals launch of first biosimilar Zarxio (filgrastim-sndz). Zarxio is the first biosimilar approved by the US Food and Drug Administration (FDA).
Honeywell, a diversified technology and manufacturing leader, introduced Safyr, a high-moisture barrier thermoformable film designed specifically to meet the requirements of India’s domestic pharmaceutical packaging market.
Glenmark Pharmaceuticals S.A., GBR 830, a novel monoclonal antibody has completed clinical phase 1 dosing. GBR 830 is an antagonist of OX40, a costimulatory receptor expressed on T cells mediating T cell activation and survival. Glenmark has now completed clinical phase I studies for GBR 830 in the Netherlands.
[adsense:336x280:8701650588]
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
